TriSalus Life Sciences
(NASDAQ) TLSI
TriSalus Life Sciences Financials at a Glance
Market Cap
$290.50M
Revenue (TTM)
$44.88M
Net Income (TTM)
-$27.31M
EPS (TTM)
-$1.41
P/E Ratio
-3.35
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$4.74
Volume
11,255
Open
$4.68
Price
$4.74
Volume
11,255
Open
$4.68
Previous Close
$4.74
Daily Range
$4.65 - $4.81
52-Week Range
$2.20 - $7.95
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$4.74
Volume
11,255
Open
$4.68
Previous Close
$4.74
Daily Range
$4.65 - $4.81
52-Week Range
$2.20 - $7.95
Estimated Earnings Date
Aug 11, 2026
TLSI News
TLSI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TriSalus Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Mary T. Szela, MBA
Website
www.trisaluslifesci.comHeadquarters
Westminster, CO 80031, US
TLSI Financials
Key Financial Metrics (TTM)
Gross Margin
85.07%
Operating Margin
-62.45%
Net Income Margin
-60.85%
Return on Equity
162.57%
Return on Capital
-4645.86%
Return on Assets
-38.48%
Earnings Yield
-29.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$290.50M
Shares Outstanding
61.42M
Volume
11.26K
Avg. Volume
453.88K
Financials (TTM)
Gross Profit
$38.18M
Operating Income
-$28.03M
EBITDA
-$20.95M
Operating Cash Flow
-$19.99M
Capital Expenditure
-$305.00K
Free Cash Flow
-$20.30M
Cash & ST Invst.
$56.55M
Total Debt
$34.49M
TriSalus Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.90M
-2.9%
Gross Profit
$7.67M
-0.0%
Gross Margin
86.18%
N/A
Market Cap
$290.50M
N/A
Market Cap/Employee
$2.64M
N/A
Employees
110
N/A
Net Income
$1.54M
+114.8%
EBITDA
$3.11M
+134.6%
Quarterly Fundamentals
Total Cash
$56.55M
+335.0%
Total Debt
$34.49M
+4.1%
Accounts Receivable
$5.22M
-4.4%
Inventory
$3.78M
-9.2%
Long Term Debt
$34.27M
+3.9%
Short Term Debt
$218.00K
+84.7%
Return on Assets
-38.48%
N/A
Return on Invested Capital
-47.35%
N/A
Free Cash Flow
-$6.62M
-26.0%
Operating Cash Flow
-$6.48M
-44.0%